Nascent Biotech Inc. Quarterly Earnings Per Share, Diluted in USD/shares from Q4 2015 to Q4 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Nascent Biotech Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q4 2015 to Q4 2022.
  • Nascent Biotech Inc. Earnings Per Share, Diluted for the quarter ending December 31, 2022 was -0.01 USD/shares, a 200% decline year-over-year.
  • Nascent Biotech Inc. annual Earnings Per Share, Diluted for 2017 was -0.09 USD/shares, a 280% decline from 2016.
  • Nascent Biotech Inc. annual Earnings Per Share, Diluted for 2016 was 0.05 USD/shares.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $0 $0 -200% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-14
Q4 2021 $0.01 +$0.02 Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q4 2020 $0 Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q1 2018 $0 $0 $0 0% Jan 1, 2018 Mar 31, 2018 10-K 2018-06-29
Q4 2017 $0 $0 $0 -167% Oct 1, 2017 Dec 31, 2017 10-Q 2018-01-31
Q3 2017 $0 $0 $0 -167% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $0.01 $0 $0 -133% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $0.05 $0 Jan 1, 2017 Mar 31, 2017 10-K 2018-06-29
Q4 2016 $0.03 +$0.05 Oct 1, 2016 Dec 31, 2016 10-Q 2018-01-31
Q3 2016 $0.03 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $0.03 Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q4 2015 $0 Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.